000148628 001__ 148628
000148628 005__ 20240229123033.0
000148628 0247_ $$2doi$$a10.1038/s41564-019-0594-3
000148628 0247_ $$2pmid$$apmid:31686029
000148628 0247_ $$2altmetric$$aaltmetric:69761566
000148628 037__ $$aDKFZ-2019-03173
000148628 041__ $$aeng
000148628 082__ $$a570
000148628 1001_ $$0P:(DE-He78)8c3dd76230733f354d346a2fbe8db355$$aStanifer, Megan$$b0$$eFirst author$$udkfz
000148628 245__ $$aAsymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells.
000148628 260__ $$aLondon$$bNature Publishing Group$$c2020
000148628 3367_ $$2DRIVER$$aarticle
000148628 3367_ $$2DataCite$$aOutput Types/Journal article
000148628 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601364192_28911
000148628 3367_ $$2BibTeX$$aARTICLE
000148628 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148628 3367_ $$00$$2EndNote$$aJournal Article
000148628 500__ $$a2020 Jan;5(1):181-191#EA:F140#LA:F140#
000148628 520__ $$aIntestinal epithelial cells (IECs) act as a physical barrier separating the commensal-containing intestinal tract from the sterile interior. These cells have found a complex balance allowing them to be prepared for pathogen attacks while still tolerating the presence of bacterial or viral stimuli present in the lumen of the gut. Using primary human IECs, we probed the mechanisms that allow for such a tolerance. We discovered that viral infections emanating from the basolateral side of IECs elicit a stronger intrinsic immune response in comparison to lumenal apical infections. We determined that this asymmetric immune response is driven by the clathrin-sorting adaptor AP-1B, which mediates the polarized sorting of Toll-like receptor 3 (TLR3) towards the basolateral side of IECs. Mice and human IECs lacking AP-1B showed an exacerbated immune response following apical stimulation. Together, these results suggest a model where the cellular polarity program plays an integral role in the ability of IECs to partially tolerate apical commensals while remaining fully responsive to invasive basolateral pathogens.
000148628 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000148628 588__ $$aDataset connected to CrossRef, PubMed,
000148628 7001_ $$0P:(DE-He78)bd6d0f168fa320c13e2027b273602455$$aMukenhirn, Markus$$b1
000148628 7001_ $$0P:(DE-He78)e66515a6be60877d105f7b2f95b81141$$aMuenchau, Stephanie$$b2
000148628 7001_ $$0P:(DE-He78)744dfecf3314a45f295ee7cbf7630a57$$aPervolaraki, Kalliopi$$b3
000148628 7001_ $$aKanaya, Takashi$$b4
000148628 7001_ $$0P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa$$aAlbrecht, Dorothee$$b5
000148628 7001_ $$aOdendall, Charlotte$$b6
000148628 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b7
000148628 7001_ $$00000-0003-3119-6993$$aHaucke, Volker$$b8
000148628 7001_ $$aKagan, Jonathan C$$b9
000148628 7001_ $$00000-0003-2493-8282$$aBartfeld, Sina$$b10
000148628 7001_ $$00000-0001-8776-9661$$aOhno, Hiroshi$$b11
000148628 7001_ $$0P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f$$aBoulant, Steeve$$b12$$eLast author$$udkfz
000148628 773__ $$0PERI:(DE-600)2845610-5$$a10.1038/s41564-019-0594-3$$n1$$p181-191$$tNature microbiology$$v5$$x2058-5276$$y2020
000148628 909CO $$ooai:inrepo02.dkfz.de:148628$$pVDB
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8c3dd76230733f354d346a2fbe8db355$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bd6d0f168fa320c13e2027b273602455$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e66515a6be60877d105f7b2f95b81141$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)744dfecf3314a45f295ee7cbf7630a57$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000148628 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000148628 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000148628 9141_ $$y2020
000148628 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNAT MICROBIOL : 2017
000148628 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148628 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148628 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148628 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148628 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148628 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148628 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000148628 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNAT MICROBIOL : 2017
000148628 9202_ $$0I:(DE-He78)F140-20160331$$kF140$$lF140 Zelluläre Polarität und virale Infektion$$x0
000148628 9200_ $$0I:(DE-He78)F140-20160331$$kF140$$lF140 Zelluläre Polarität und virale Infektion$$x0
000148628 9201_ $$0I:(DE-He78)F140-20160331$$kF140$$lF140 Zelluläre Polarität und virale Infektion$$x0
000148628 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000148628 980__ $$ajournal
000148628 980__ $$aVDB
000148628 980__ $$aI:(DE-He78)F140-20160331
000148628 980__ $$aI:(DE-He78)C060-20160331
000148628 980__ $$aUNRESTRICTED